Literature DB >> 1415525

Stimulation of protein synthesis in pig skeletal muscle by infusion of amino acids during constant insulin availability.

P W Watt1, M E Corbett, M J Rennie.   

Abstract

Incorporation of L-[1-13C]leucine into muscle protein and leg exchange of L-[15N]phenylalanine were used to assess the effects over 240 min of amino acid supply on leg protein turnover in anesthetized, overnight-fasted (Landrace x Great White) female pigs. In all pigs, plasma insulin and glucagon stability was ensured by infusion of somatostatin (8 micrograms.kg-1.h-1), insulin (6 mU.kg-1.h-1), and glucagon (72 ng.kg-1.h-1). Mixed amino acid infusion (260 mg.kg-1.h-1) caused a 2- to 2.5-fold elevation of arterial plasma phenylalanine and leucine; in a control group (no amino acid infusion), an increase in phenylalanine and leucine concentration was observed as a result of the hormone clamp. Plasma insulin and glucagon concentrations were steady and not significantly different between control and amino acid-infused groups during the final 240 min, but plasma glucose fell (P less than 0.05) in both groups (4.57 +/- 0.17 to 3.15 +/- 0.73 mM). Muscle protein synthetic rate (estimated from the change in L-[1-13C]leucine incorporation compared with labeling of [13C]leucyl-tRNA) was greater in amino acid-infused (0.076%/h) than in control (0.053%/h) pigs. In the control group, leg amino acid balance was negative (Phe alone, -10.2 +/- 9.4 nmol Phe.100 g-1.min-1; total amino acids, -0.27 +/- 1.04 micrograms amino N.100 g-1.min-1), but during amino acid infusion, balance was positive (Phe alone, +33.6 +/- 8.8 nmol Phe.100 g-1.min-1; total amino acids, +58.2 +/- 4.9 micrograms amino N.100 g-1.min-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415525     DOI: 10.1152/ajpendo.1992.263.3.E453

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.

Authors:  Anthony J Kee; Lydie Combaret; Thomas Tilignac; Bertrand Souweine; Eveline Aurousseau; Michel Dalle; Daniel Taillandier; Didier Attaix
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

2.  Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics.

Authors:  P Tessari; M Zanetti; R Barazzoni; M Vettore; F Michielan
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

3.  Exogenous amino acids stimulate net muscle protein synthesis in the elderly.

Authors:  E Volpi; A A Ferrando; C W Yeckel; K D Tipton; R R Wolfe
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 4.  The application of stable-isotope tracers to study human musculoskeletal protein turnover: a tale of bag filling and bag enlargement.

Authors:  D Joe Millward; Ken Smith
Journal:  J Physiol       Date:  2018-09-07       Impact factor: 5.182

5.  Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise.

Authors:  Benjamin F Miller; Jens L Olesen; Mette Hansen; Simon Døssing; Regina M Crameri; Rasmus J Welling; Henning Langberg; Allan Flyvbjerg; Michael Kjaer; John A Babraj; Kenneth Smith; Michael J Rennie
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

Review 6.  Leucine is a major regulator of muscle protein synthesis in neonates.

Authors:  Daniel A Columbus; Marta L Fiorotto; Teresa A Davis
Journal:  Amino Acids       Date:  2014-11-20       Impact factor: 3.520

Review 7.  Nutritionally essential amino acids and metabolic signaling in aging.

Authors:  E Lichar Dillon
Journal:  Amino Acids       Date:  2012-12-14       Impact factor: 3.520

8.  Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics.

Authors:  P Tessari; G Garibotto; S Inchiostro; C Robaudo; S Saffioti; M Vettore; M Zanetti; R Russo; G Deferrari
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.